ArticleThe European respiratory journal2023
New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic.
Abstract readEditorial
In one paragraph
Article in The European respiratory journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- High rates of viral co-detection in outpatient children with acute respiratory infections after the easing of preventive measures against Covid-19 in Germany.BMC infectious diseases · 2026Observational
- Burden of RSV-Associated Inpatient Care and Emergency Service Utilization in Two German Pediatric Centers Across Six Seasons Including the First Nirsevimab Year.Children (Basel, Switzerland) · 2026Article
- Epidemiological patterns and trends of respiratory syncytial virus in Guangdong Province, China, 2019-2023.Frontiers in public health · 2026Article
- Epidemiological characteristics of single and co-infections with upper respiratory tract pathogens among children in eastern China: a retrospective study.Frontiers in pediatrics · 2026Article
- Post-COVID-19 Seasonality of Influenza, Respiratory Syncytial Virus, and SARS-CoV-2 Among Hospitalized Children in Western Iran: A Molecular Surveillance Study (2023-2024).Journal of epidemiology and global health · 2025Article
- Awareness of respiratory syncytial virus and other respiratory disease vaccines among healthcare professionals and their patients in Italy: Insights from a literature review and a web-based survey.Human vaccines & immunotherapeutics · 2025Review
- Genetic and Epidemiological Insights Into Respiratory Syncytial Virus Infections: A Comparative Study of Hospitalized Versus Community Cases in Portugal (2021-2023).Influenza and other respiratory viruses · 2025Article
- Healthcare-Seeking behavior for acute respiratory infections in a community population in Southwest China during the 2021-2023 influenza seasons.BMC infectious diseases · 2025Article
- Seasonal epidemiological and clinical characteristics of pediatric patients with respiratory syncytial virus infection by age during COVID-19: a cross-sectional study.Translational pediatrics · 2025Article
- Hospitalisation trends of respiratory syncytial virus (RSV) infection in adults, six European countries, before and during COVID-19, 2016 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
- Addressing the Underestimated Burden of RSV in Older Adults in Europe: Epidemiology, Surveillance Gaps, and Public Health Implications.Vaccines · 2025Review
- Epidemic features and megagenomic analysis of childhoodEmerging microbes & infections · 2024Article
- Article
- Article
- Genotype Analysis of Respiratory Syncytial Virus Before and After the COVID-19 Pandemic Using Whole-Genome Sequencing: A Prospective, Single-Center Study in Korea From 2019 to 2022.Journal of Korean medical science · 2024Article
- A robust, scalable, and cost-efficient approach to whole genome sequencing of RSV directly from clinical samples.Journal of clinical microbiology · 2024Article
- Coronavirus and co-infections: A Saudi Arabian perspective.Saudi journal of biological sciences · 2023Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
39 authors.
Anne C TeirlinckNational Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, Bilthoven, The Netherlands anne.teirlinck@rivm.nl.ORCID 0000-0002-1172-8975
Caroline K JohannesenStatens Serum Institut, Copenhagen, Denmark.
Eeva K BrobergEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Pasi PenttinenEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.ORCID 0000-0001-6929-1086
Harry CampbellUsher Institute, University of Edinburgh, Edinburgh, UK.
Harish NairUsher Institute, University of Edinburgh, Edinburgh, UK.
Rachel M ReevesIndependent researcher, Edinburgh, UK.ORCID 0000-0002-8949-1568
Håkon BøåsNorwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0002-5917-1563
Mia BryttingPublic Health Agency of Sweden, Stockholm, Sweden.
Wei CaiRobert Koch Institute, Berlin, Germany.
AnnaSara CarnahanPublic Health Agency of Sweden, Stockholm, Sweden.
Jean-Sebastien CasalegnoCentre National de Référence des virus des infections respiratoires dont la grippe, Hospices Civils de Lyon, Lyon, France.
Kostas DanisEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.ORCID 0000-0001-6727-7344
Cillian De GascunHealth Protection Surveillance Centre, Dublin, Ireland.
Joanna EllisUK Health Security Agency, London, UK.
Hanne-Dorthe EmborgStatens Serum Institut, Copenhagen, Denmark.
Manuel GijonFoundazione PENTA Onlus, Padova, Italy.
Raquel GuiomarNational Institute of Health Ricardo Jorge, Lisbon, Portugal.
Siddhivinayak S HirveWorld Health Organization, Geneva, Switzerland.
Helena JiřincováNational Institute of Public Health, Prague, Czech Republic.
Hanna NohynekFinnish National Institute for Health and Welfare, Helsinki, Finland.
Jesus Angel OlivaInstituto de Salud Carlos III Madrid, CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.ORCID 0000-0003-4080-7864
Richard Osei-YeboahUsher Institute, University of Edinburgh, Edinburgh, UK.ORCID 0000-0003-4622-3691
John PagetNetherlands Institute for Health Services Research (Nivel), Utrecht, The Netherlands.
Gatis PakarnaRiga East University Hospital, Riga, Latvia.
Richard PebodyWorld Health Organization Regional Office for Europe, Copenhagen, Denmark.
Lance PresserNational Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, Bilthoven, The Netherlands.
Marie RappPublic Health Agency of Sweden, Stockholm, Sweden.
Janine ReicheRobert Koch Institute, Berlin, Germany.
Ana Paula RodriguesNational Institute of Health Ricardo Jorge, Lisbon, Portugal.
Elina SeppäläNorwegian Institute of Public Health, Oslo, Norway.
Maja SocanNational Institute of Public Health, Ljubljana, Slovenia.
Karol SzymanskiNational Institute of Public Health NIH National Research Institute, Warsaw, Poland.ORCID 0000-0003-3269-0774
Ramona TrebbienStatens Serum Institut, Copenhagen, Denmark.
Jaromíra VečeřováNational Institute of Public Health, Prague, Czech Republic.
Sylvie van der WerfInstitut Pasteur, Université Paris Cité, CNRS UMR3569, Paris, France.ORCID 0000-0002-1148-4456
Maria ZambonUK Health Security Agency, London, UK.
Adam MeijerNational Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, Bilthoven, The Netherlands.ORCID 0000-0001-8074-7582
Thea K FischerStatens Serum Institut, Copenhagen, Denmark.
Funding
World Health Organization 001
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19Respiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsHumansPandemics
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.